Mental Health News and Research

Latest Mental Health News and Research

CRN reinforces importance of DHA before, during and after pregnancy

In response to a study regarding fish oil use during pregnancy published in the October 19 issue of the Journal of the American Medical Association (JAMA), the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, reminds pregnant and lactating women of the undisputed importance of consuming the recommended amounts of docosahexaenoic acid (DHA) throughout pregnancy.

20 Oct 2010

Department of Veterans Affairs advertises Suicide Prevention Hotline

This week, nearly 1,200 life-saving advertisements will go up on city buses, bus shelters, rail and subway stations across the Nation displaying a message of hope for those who have served their country and may be facing an emotional crisis. The Department of Veterans Affairs (VA) is advertising its Suicide Prevention Hotline through Jan. 9, 2011.

20 Oct 2010

Study finds ketamine-propofol combination effective for pediatric procedural sedation

Procedural sedation and analgesia is an essential element of care for children requiring painful procedures in the emergency department. The practice of combining ketamine and propofol, two common medications used in emergency departments, has become more popular. However, until recently, it was unclear whether this practice was superior to the use of either agent alone, especially in children.

20 Oct 2010

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Researchers at the Allen Institute for Brain Science have found that the same genes have different activity patterns in the brain in individuals with different genetic backgrounds. These findings may help to explain individual differences in the effectiveness and side-effect profiles of therapeutic drugs and thus have implications for personalized medicine. The study is available in this week's online early edition of the Proceedings of the National Academy of Sciences (www.pnas.org).

20 Oct 2010

Project LAUNCH receives $19 million from SAMHSA

The Substance Abuse and Mental Health Services Administration (SAMHSA) is awarding over $19 million in Project LAUNCH (Linking Actions for Unmet Needs in Children's Health) grants to tribal and community-based programs over the next five years. Project LAUNCH promotes the wellness of children from birth to eight years of age by addressing the physical, emotional, social, cognitive and behavioral aspects of their development.

20 Oct 2010

Consumption of fish oil capsules during pregnancy does not reduce post-natal depression

A University of Adelaide study has found no evidence that taking fish oil capsules during pregnancy can help reduce the risk of post-natal depression, contrary to international recommendations.

20 Oct 2010

$IOF urges health professionals and public to recognize signs of spinal fractures$

IOF urges health professionals and public to recognize signs of spinal fractures

A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.

20 Oct 2010

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

The Washington Post: "A Maryland health information exchange that will allow hospitals, physicians, labs and radiology centers to share patient information within the state went live last week. Three hospitals, three radiology centers, Quest Diagnostics and the Laboratory Corp. of America are already participating in the exchange."

20 Oct 2010

Alexza reacquires U.S. and Canadian rights for Staccato Loxapine from BLS

Alexza Pharmaceuticals, Inc. announced today that it has reacquired the U.S. and Canadian rights for AZ-004 (Staccato® loxapine) from Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc.. AZ-004 is being developed for the rapid treatment of agitation in schizophrenia or bipolar disorder patients.

20 Oct 2010

Fish oil not as good for pregnant mums as thought: Study

According to a new Australian study, taking fish oil / docosahexaenoic acid (DHA) supplements during pregnancy does not appear to reduce the risk of postpartum depression of mothers or boost the language development and cognitive skills of their children.

19 Oct 2010

Pharmacy graduate awarded national recognition for pioneering research in genetics

A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.

19 Oct 2010

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Johnson & Johnson today announced sales of $15.0 billion for the third quarter of 2010, a decrease of 0.7% as compared to the third quarter of 2009. Operational results increased 0.1% and the negative impact of currency was 0.8%. Domestic sales declined 2.5%, while international sales increased 1.1%, reflecting operational growth of 2.6% and a negative currency impact of 1.5%.

19 Oct 2010

Iraqi Cultural Center to host first-of its-kind public discussion among behavioral health specialists

On Oct 21, 2010, the Iraqi Cultural Center in Washington, D.C. will host a first-of its-kind public discussion among behavioral health specialists from Iraq and the U.S. about Iraq's increasingly effective behavioral healthcare programs and how the lessons learned in treating severe trauma there can be applied in the U.S. and elsewhere.

19 Oct 2010

UnitedHealth Group consolidated third quarter revenues increase 9% to $23.7 billion

UnitedHealth Group today reported third quarter results, including strong revenue growth in both its Health Benefits and Health Services business groups. Third quarter 2010 net earnings were $1.14 per share. Key performance metrics and costs were in line with or better than Company expectations.

19 Oct 2010

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Genetic variants associated with increased susceptibility to psoriasis are reported in five papers published online this week in Nature Genetics. Psoriasis is a chronic and recurrent skin disease, and one of the most prevalent autoimmune diseases, with a global prevalence of 2-3%.

19 Oct 2010

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

A recent court decision gave a group of California counties another chance to challenge what they contend are severe Medicare underpayments that jeopardize access to care across the country.

19 Oct 2010

Study indicates vitamin D deficiency may increase lung transplant rejection

Vitamin D deficiency is associated with a significant increase in lung transplant rejection, according to research conducted at Loyola University Health System (LUHS). These data were presented Monday at The American Society for Bone and Mineral Research 2010 annual meeting in Toronto, Ontario.

19 Oct 2010

Studies explore impact of upper GI conditions on sleep

The impact of upper GI conditions, like gastroesophageal reflux disease (GERD) and functional dyspepsia, on sleep—and treatments aimed at providing relief to heartburn/acid reflux patients who suffer from disordered sleep—were explored in three new studies related to sleep dysfunction presented today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

2010 Lilly Reintegration Award honorees announced

For the 14th straight year, Eli Lilly and Company honors mental health professionals and individuals for their exceptional contributions and achievements in helping those battling serious mental illness.

18 Oct 2010

Lannett announces launch of Fluphenazine HCl Tablets

Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it has commenced shipping Fluphenazine HCl Tablets USP, the generic equivalent of Prolixin®, in 1 mg, 2.5 mg, 5 mg and 10 mg dosages. For the 12 months ended September 2010, Fluphenazine HCl Tablets USP, 1 mg, 2.5 mg, 5 mg, & 10 mg had U.S. sales of approximately $28 million at Average Wholesale Price.

18 Oct 2010

Mental Health News and Research

Latest Mental Health News and Research

CRN reinforces importance of DHA before, during and after pregnancy

Department of Veterans Affairs advertises Suicide Prevention Hotline

Study finds ketamine-propofol combination effective for pediatric procedural sedation

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Project LAUNCH receives $19 million from SAMHSA

Consumption of fish oil capsules during pregnancy does not reduce post-natal depression

IOF urges health professionals and public to recognize signs of spinal fractures

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

Alexza reacquires U.S. and Canadian rights for Staccato Loxapine from BLS

Fish oil not as good for pregnant mums as thought: Study

Pharmacy graduate awarded national recognition for pioneering research in genetics

Johnson & Johnson third quarter sales decrease 0.7% to $15.0 billion

Iraqi Cultural Center to host first-of its-kind public discussion among behavioral health specialists

UnitedHealth Group consolidated third quarter revenues increase 9% to $23.7 billion

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

Study indicates vitamin D deficiency may increase lung transplant rejection

Studies explore impact of upper GI conditions on sleep

2010 Lilly Reintegration Award honorees announced

Lannett announces launch of Fluphenazine HCl Tablets

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Mental Health News and Research

Latest Mental Health News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in